| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.95B | $5.41B | $4.93B |
| YoY Revenue Growth % | -8.5% | +9.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $849.0M | $1.27B | $708.0M |
| Operating Margin % | 17.2% | 23.5% | 14.4% |
| Net Income (GAAP) | $83.0M | $683.0M | $270.0M |
| EBITDA (Normalized) | $967.4M | $1.38B | $885.6M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $891.0M | $1.25B | $999.0M |
| Capital Expenditures (CapEx) | $148.0M | $145.0M | $222.0M |
| Free Cash Flow (FCF) | $743.0M | $1.10B | $777.0M |
| FCF Margin % | 15.0% | 20.4% | 15.8% |
| Return on Invested Capital (ROIC %) | 8.4% | 11.8% | 15.6% |
| Cash & Short-Term Equivalents | $280.0M | $144.0M | — |
| Total Debt (Short + Long Term) | $6.22B | $6.40B | $1.39B |
| Total Stockholders' Equity | $2.06B | $2.26B | $2.84B |